Clinical Trial

PARTNER 3 Trial - Mitral Valve in Valve

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
To assess the safety and effectiveness of the SAPIEN 3 transcatheter heart valve in patients with a failing mitral bioprosthetic valve.
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2017-06-19; most recent amendment 2025-10-31.
Status change: Recruiting → Active, Not Recruiting 2021-09-02
Status change: Not Yet Recruiting → Recruiting 2018-04-24
Trial Details
NCT Number NCT03193801
Lead Sponsor Edwards Lifesciences
Conditions Mitral Valve Insufficiency, Mitral Valve Disease, Mitral Valve Regurgitation, Heart Failure
Enrollment 53 participants
Start Date 2018-02-01
Primary Completion 2022-08-16 (estimated)
Study Completion 2031-08 (estimated)
Updated on ClinicalTrials.gov 2025-11-05